Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population-Reference-Cited by-全球学者库

Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population

Published:2014-08-31 Issue:15 Volume:74 Page:1569-1575
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Na Rong¹²,Ye Dingwei³,Liu Fang⁴,Chen Haitao⁴,Qi Jun⁵,Wu Yishuo¹²,Zhang Guiming³,Wang Meilin⁶,Wang Wenying⁶,Sun Jielin⁶,Yu Guopeng¹²⁴,Zhu Yao³,Ren Shancheng⁷,Zheng S. Lilly⁶,Jiang Haowen¹²,Sun Yinghao⁷,Ding Qiang¹²,Xu Jianfeng¹²⁴⁶

Affiliation:

1. Fudan Institute of Urology; Fudan University; Shanghai China

2. Department of Urology; Huashan Hospital; Fudan University; Shanghai China

3. Department of Urology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College; Fudan University; Shanghai China

4. State Key Laboratory of Genetic Engineering, School of Life Science; Fudan University; Shanghai China

5. Department of Urology, Xinhua Hospital, School of Medicine; Shanghai Jiaotong University; Shanghai China

6. Center for Cancer Genomics; Wake Forest School of Medicine; Winston-Salem North Carolina

7. Department of Urology, Shanghai Changhai Hospital; Second Military Medical University; Shanghai China

Funder

Key Project of the National Natural Science Foundation of China

National Key Basic Research Program Grant

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

Reference27 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. Howlader NNA Krapcho M Garshell J Neyman N Altekruse SF Kosary CL Yu M Ruhl J Tatalovich Z Cho H Mariotto A Lewis DR Chen HS Feuer EJ Cronin KA SEER Cancer Statistics Review, 1975-2010, National Cancer Institute, Bethesda http://seercancergov/csr/1975_2010/

4. Trends in prostate cancer in the United States;Brawley;J Natl Cancer Inst Monogr,2012

5. The burden of prostate cancer in Asian nations;Cullen;J Carcinog,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2022-12

2. The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone;International Urology and Nephrology;2022-02-24

3. The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy;Journal of Clinical Medicine;2021-10-20

4. A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort;Frontiers in Oncology;2021-10-19

5. Diagnostic accuracy of [-2]proPSA versus Gleason score and Prostate Health Index versus Gleason score for the determination of aggressive prostate cancer: a systematic review;JBI Evidence Synthesis;2021-03-17